Table 3.
Progression | No. patients | Rate of progression | Median or average progression time | Ref. |
AIN II/III to SCC | 72 | 11% | 42 mo | [33] |
AIN III to SCC | 35 | 8.6% | 53 mo | [34] |
AIN I to AIN III | 199 | 12.6% (8.1/100 person-years) | 18 mo | [35] |
ASCUS/AIN I to AIN II/III | 556 | 24.5% (10.5/100 person-years) | 36 mo | [36] |
HSIL to SCC | 138 | 19.6% | 57 mo. w/prevalent HSIL; 64 mo. w/incident HSIL | [37] |
ASCUS: Atypical squamous cells of undetermined significance; LSIL: Low-grade squamous intraepithelial lesion; HSIL: High-grade squamous intraepithelial lesion; AIN: Anal intraepithelial neoplasia; SCC: Squamous cell carcinoma.